Home / Safety / Llama for the pharmaceutical industry
MetaHow safe is Llama for the pharmaceutical industry?
Llama has a specific GDPR concern. The Llama 4 Acceptable Use Policy prohibits the multimodal models for businesses headquartered in the EU. Dutch companies therefore may not install the multimodal Llama 4 models themselves under the licence terms. Weigh this heavily before using it in the pharmaceutical industry.
Where does Llama stand in the pharmaceutical industry?
Shared spot 19 of 25 options for the pharmaceutical industry (professional tools and general assistants) on GDPR profile. 7 options, like Llama, have a profile to watch. Each tile is an option we track for this field; click for the check.
Published safeguards
Self-hosting gives full data control within your own EU infrastructure, a strong GDPR argument.
How to use Llama safely
- Use the business variant and sign a data processing agreement (DPA).
- Do not enter unnecessary personal data into prompts; anonymise where possible.
- Enable EU data residency where the provider offers it.
- Keep a professional in the loop: in this sector it concerns health data of trial participants and patients (special category personal data under art.
Stronger or equally strong in the pharmaceutical industry
CradleCradle (Amsterdam, the Netherlands and Zürich, Switzerland)CastorCastor (Amsterdam, Netherlands)BiolevateBiolevate (Paris, France)Aily LabsAily Labs GmbH (Munich, Germany)ClaudeAnthropicLatest developments
Meta released Muse Spark Open (around 816B parameters, open weights). Unlike Llama 4, the Muse Model License does not exclude companies in the EU; EU licensees contract with Meta Platforms Ireland. Conditions: attribution 'Built with Muse Spark Open', a separate agreement for model-as-a-service above $20 million in revenue, and access via a manual request with name, date of birth and organisation name. Self-hosting keeps data within your own infrastructure. source
The Acceptable Use Policy excludes companies headquartered in the EU from the multimodal Llama 4 models, due to regulatory uncertainty around the EU AI Act. source
Questions
- How safe is Llama for the pharmaceutical industry?
- Llama has a concrete GDPR concern. The Llama 4 Acceptable Use Policy prohibits the multimodal models for businesses headquartered in the EU. Dutch businesses therefore may not install the multimodal Llama 4 models themselves under the licence terms. Weigh this heavily before you deploy it in the pharmaceutical industry. There is a concrete GDPR concern, read the details on the page.
- Does Llama train on my data?
- Self-hosting gives full data control within your own EU infrastructure, a strong GDPR argument.
- What should I look out for with AI in the pharmaceutical industry?
- This sector involves health data of trial participants and patients (special category personal data under Article 9 GDPR) and confidential research data. Ask every provider where the data is stored and whether it is used to train models: Castor hosts in the Netherlands (Google Cloud europe-west4) and does not share data or models between customers, Cradle states that source data never goes to third-party AI models, Iris.ai hosts on AWS in Ireland and Germany. Biolevate and Ennov also run in private cloud or on-premises. With Veeva Vault AI and Yseop, texts go to Anthropic models via Amazon Bedrock; check the region and the data processing agreement. If you work in GxP processes, an AI tool must also be validated (EU GMP Annex 11) and a competent employee remains responsible. For AI in medicines development, the EMA has a reflection paper (2024) and is working with the FDA on joint principles.
Source documents
Everything about Llama Best AI for the pharmaceutical industry
Summarised by the editorial team from provider documentation · not legal advice
Last checked: 5 November 2026 · How we check
Source: , checked on 5 November 2026
Every Friday: what changed in AI for the pharmaceutical industry
New models, prices, oversight and tools, with sources and what it means for you. One email a week, unsubscribe with one click.